Long Read Sequencing Market Is Booming So Rapidly 2025-2032 - BGI Genomics Co., Ltd., Roche Sequencing Solutions, QIAGEN N.V.

The Global Long Read Sequencing Market size is estimated to be valued at USD 784.9 Mn in 2025 and is expected to reach USD 5,224.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 31.1% from 2025 to 2032. This market forecast underscores strong market growth driven by declining per-run costs and wider adoption in oncology, agriculture genomics, and infectious disease surveillance.

The Global Long Read Sequencing Market has witnessed a paradigm shift as researchers demand more accurate assemblies and structural variant detection. Fueled by breakthroughs in nanopore and single-molecule real-time platforms, industry size expanded rapidly in 2024-2025. Our market analysis indicates robust business growth on the back of large-scale genomics projects and precision medicine initiatives worldwide.

Get a Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/6582

Key Takeaways

• Region:
- North America: Leading research funding and large-scale consortia accelerate adoption.
- Latin America: Growing academic-industry partnerships in Brazil and Argentina boost pilot projects.
- Europe: EU initiatives like Horizon Europe support population genomics, enhancing market insights.
- Asia Pacific: China and India scale up sequencing capacity for public health genomics.
- Middle East: Strategic investments in genomics centers foster market opportunities.
- Africa: Emerging disease surveillance programs spur infrastructure upgrades.

• Market Segment:

- Sequencing Technology: Single-molecule real-time (SMRT) and nanopore platforms power de novo assemblies (use case: complex plant genomes).
- Application: Genomics and transcriptomics subsegments support rare disease variant discovery (example: full-length transcript mapping).
- End User: Academic & research institutes, pharmaceutical & biotech companies drive custom assay development (use case: oncology biomarker panels).

Growth Factors

• Cost per base pair dropped by 18% in 2024, making long reads competitively priced vs. short reads-this Global Long Read Sequencing Market revenue decline fueled a 25% increase in large-scale population studies.
• Expanded production capacity: A major SMRT platform manufacturer ramped throughput by 30% in 2024, directly boosting global supply-side indicators.
• Rising demand from precision medicine: Over 60% of clinical genomics labs integrated long-read assays in 2025, underscoring market drivers behind sequencing projects for structural variant detection.

Market Trends

• Portable sequencing is on the rise: Nanopore handheld devices grew shipments by 40% year-on-year, reflecting emerging Global Long Read Sequencing Market share gains outside core labs.
• Hybrid assembly workflows combining short and long reads now represent over 45% of published genome studies, highlighting a shift in analytical best practices.
• Automated library prep systems adoption surged 35% in 2024, streamlining sample processing and shaping future market trends toward end-to-end solutions.

Get discount on Purchase report @ https://www.coherentmarketinsights.com/insight/buy-now/6582

Actionable Insights

• Production Capacity: Leading suppliers reported a combined 50% capacity increase in 2024, directly correlating to a 28% supply-side growth.
• Pricing: Average nanopore run price fell from USD 900 to USD 780 per flow cell between Q1 and Q4 2024, enhancing affordability.
• Exports & Imports: Asia Pacific imported 25% more long-read sequencers in 2024, while North America exported 18% more consumables.
• Use Case Demand: Oncology applications rose 30% as long-read platforms uncovered structural variants missed by short-read methods.
• Micro-indicators: Turnaround times dropped from 10 to 7 days on average, spurring broader clinical lab adoption.
• Nano-size indicators: Kit fill volumes optimized by 15%, reducing reagent waste and improving run consistency.

Key Players

◘ Illumina Inc.
◘ Pacific Biosciences of California, Inc.
◘ Oxford Nanopore Technologies Ltd.
◘ BGI Genomics Co., Ltd.
◘ Roche Sequencing Solutions
◘ QIAGEN N.V.
◘ Thermo Fisher Scientific Inc.
◘ Genapsys Inc.
◘ Nabsys, Inc.
◘ Eurofins Scientific SE
◘ DNASTAR, Inc.
◘ Analytik Jena AG

• Competitive Strategies:

- Illumina's acquisition of Grail in 2024 expanded its oncology pipeline, yielding a 22% uptick in diagnostic service revenue.
- Pacific Biosciences launched higher-throughput HiFi chips in mid-2024, reducing per-gigabase cost by 15%.
- Oxford Nanopore's PromethION X roll-out in late 2024 secured multi-year contracts with three national genomics centers, boosting annual bookings by 30%.

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/6582

FAQs

1. Who are the dominant players in the Global Long Read Sequencing Market?
Major players include Illumina Inc., Pacific Biosciences, Oxford Nanopore, BGI Genomics, and Roche, each leading in unique platform capabilities.

2. What will be the size of the Global Long Read Sequencing Market in the coming years?
The market is projected to grow from USD 784.9 Mn in 2025 to USD 5,224.1 Mn by 2032 at a 31.1% CAGR, per our market report.

3. Which end-user industry has the largest growth opportunity?
Pharmaceutical & biotech companies represent the largest growth segment, driven by demand for novel therapeutic target discovery and companion diagnostics.

4. How will market development trends evolve over the next five years?
Trends include integration of portable sequencing, hybrid assembly workflows, and end-to-end automation, collectively redefining throughput and cost efficiency.

5. What is the nature of the competitive landscape and challenges in the Global Long Read Sequencing Market?
Competition centers on throughput, read accuracy, and cost. Key challenges involve standardizing data analysis pipelines and ensuring consistent read quality for clinical use.

6. What go-to-market strategies are commonly adopted in the Global Long Read Sequencing Market?
Vendors pursue strategic partnerships with research consortia, bundle consumables with service agreements, and invest in on-site sequencing training to drive customer loyalty.

About Us:

With a proven excellence in market research, Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

☎️ Contact Us:

533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

This release was published on openPR.